Price erosion symptoms: Dr Reddy#39;s Laboratories plans to launch value-added drugs in US

As part of the diversification and new market entry strategy, DRL plans to re-focus some of its Research and Development resources to service the high potential branded generics markets such as China, Russia and other emerging markets.

from Moneycontrol Business News https://ift.tt/2Xt9bec